The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Lacrisert Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for ophthalmologists, optometrists, and prescribers managing Lacrisert availability issues for patients with moderate to severe dry eye disease in 2026.
Latanoprost Shortage: What Providers and Prescribers Need to Know in 2026
Ophthalmologists and optometrists managing latanoprost-dependent patients need to understand the 2026 supply landscape — and have clear substitution protocols ready.
Levofloxacin Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on the levofloxacin IV shortage in 2026 for providers and prescribers. Includes shortage data, therapeutic alternatives, and patient access tools.
Likmez Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview for prescribers on Likmez availability in 2026, including when to prescribe it, pharmacy access barriers, and evidence-based alternatives.
37,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
Linzess Shortage: What Providers and Prescribers Need to Know in 2026
Linzess isn't in an FDA shortage, but patient access barriers are real. What providers need to know about prior auth, cost, alternatives, and patient support in 2026.
Lithium Carbonate Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for providers on Lithium Carbonate availability in 2026—including formulation stocking gaps, monitoring considerations, and alternative management strategies.
Lo Zumandimine 28 Day Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for prescribers on Lo Zumandimine 28 Day availability in 2026, including therapeutic equivalents, prescribing strategies, and patient access tools.
Lotemax Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for ophthalmologists and optometrists on Lotemax availability, formulary barriers, and management strategies for patients who cannot access loteprednol in 2026.
Loteprednol Etabonate: What Providers and Prescribers Need to Know in 2026
A clinical overview of Loteprednol Etabonate supply, formulary status, and prescribing considerations for ophthalmologists and optometrists in 2026.
Low-Ogestrel Shortage: What Providers and Prescribers Need to Know in 2026
Clinical guide for providers on Low-Ogestrel availability in 2026. Covers supply status, bioequivalent substitutes, patient counseling, and prescribing strategies.
Lubiprostone Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview of Lubiprostone availability in 2026 for GI providers and prescribers: shortage status, prescribing considerations, alternatives, and patient tools.
Lunesta Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for providers on Lunesta and eszopiclone availability issues in 2026: what's driving stock gaps, how to counsel patients, and alternatives to consider.